• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶Cα(PKCα)以p53依赖的方式调节携带程序性死亡配体1(PDL1)的小细胞外囊泡的分泌。

PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner.

作者信息

Zhang Ren, Liao Weilin, Chen Xi, Wang Junyi, Li Jiaqi, Chen Geer, Wu Weiyu, Wang Xiaoxuan, Zhang Yao, Chen Ziyu, Zhu Xiaoyu, Lin Zicong, Zhu Yizhun, Ma Lijuan, Yu Haijie

机构信息

School of Pharmacy, Faculty of Medicine & State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

出版信息

Cell Death Dis. 2025 Jan 14;16(1):19. doi: 10.1038/s41419-025-07341-5.

DOI:10.1038/s41419-025-07341-5
PMID:39809736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11733117/
Abstract

Small extracellular vesicles (sEVs), carrying PD-L1, have been implicated in immune evasion and tumor progression. However, understanding how PD-L1 sEVs are secreted still needs to be improved. We found that the secretion dynamics of PD-L1 sEVs is similar to that of other sEVs. Intracellular calcium and the associated downstream PKC signaling plays pivotal roles in releasing PD-L1 sEVs in non-small cell lung cancer cells (NSCLC). Particularly, we observed that knocking down PKCα has profound impacts on PD-L1 sEVs secretion, especially in the resting state and in the activated state, when induced by an intracellular calcium rise. Furthermore, our study revealed that PKCα regulates PD-L1 expression and PD-L1 sEVs secretion by influencing STAT1 phosphorylation and nuclear translocation in a p53-dependent manner. Notably, p53 can regulate STAT1 phosphorylation and nuclear localization, but it does not affect PKCα expression. This suggests that PKCα plays a significant role in regulating PD-L1 expression. Our findings suggest that targeting PKCα to modulate PD-L1 dynamics in NSCLC may be a promising therapeutic strategy to enhance the efficacy of immunotherapeutic interventions.

摘要

携带程序性死亡受体配体1(PD-L1)的小细胞外囊泡(sEVs)与免疫逃逸和肿瘤进展有关。然而,对PD-L1 sEVs分泌方式的了解仍有待完善。我们发现,PD-L1 sEVs的分泌动力学与其他sEVs相似。细胞内钙及相关的下游蛋白激酶C(PKC)信号在非小细胞肺癌(NSCLC)细胞释放PD-L1 sEVs过程中起关键作用。特别地,我们观察到敲低PKCα对PD-L1 sEVs的分泌有深远影响,尤其是在静息状态和细胞内钙升高诱导的激活状态下。此外,我们的研究表明,PKCα通过以p53依赖的方式影响信号转导和转录激活因子1(STAT1)的磷酸化和核转位,来调节PD-L1的表达及PD-L1 sEVs的分泌。值得注意的是,p53可调节STAT1的磷酸化和核定位,但不影响PKCα的表达。这表明PKCα在调节PD-L1表达中起重要作用。我们的研究结果表明,在NSCLC中靶向PKCα以调节PD-L1动态变化可能是一种有前景的治疗策略,可提高免疫治疗干预的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/ae233f09a93d/41419_2025_7341_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/7ddc3051c54d/41419_2025_7341_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/fd91d84397c6/41419_2025_7341_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/8d1e6a27ce6a/41419_2025_7341_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/29d774bac70d/41419_2025_7341_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/cfcb0e764348/41419_2025_7341_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/1d477d1ddb84/41419_2025_7341_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/67ddfaf046fc/41419_2025_7341_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/ae233f09a93d/41419_2025_7341_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/7ddc3051c54d/41419_2025_7341_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/fd91d84397c6/41419_2025_7341_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/8d1e6a27ce6a/41419_2025_7341_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/29d774bac70d/41419_2025_7341_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/cfcb0e764348/41419_2025_7341_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/1d477d1ddb84/41419_2025_7341_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/67ddfaf046fc/41419_2025_7341_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/ae233f09a93d/41419_2025_7341_Fig8_HTML.jpg

相似文献

1
PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner.蛋白激酶Cα(PKCα)以p53依赖的方式调节携带程序性死亡配体1(PDL1)的小细胞外囊泡的分泌。
Cell Death Dis. 2025 Jan 14;16(1):19. doi: 10.1038/s41419-025-07341-5.
2
EGFR Mutation and TKI Treatment Promote Secretion of Small Extracellular Vesicle PD-L1 and Contribute to Immunosuppression in NSCLC.EGFR 突变和 TKI 治疗促进 NSCLC 中小细胞外囊泡 PD-L1 的分泌并导致免疫抑制。
Biomolecules. 2024 Jul 9;14(7):820. doi: 10.3390/biom14070820.
3
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.ILT4 抑制可预防 TAM 和功能失调 T 细胞介导的免疫抑制,并增强 EGFR 激活的 NSCLC 中抗 PD-L1 治疗的疗效。
Theranostics. 2021 Jan 19;11(7):3392-3416. doi: 10.7150/thno.52435. eCollection 2021.
4
NSUN2/ALYREF axis-driven mC methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer.NSUN2/ALYREF轴驱动的m⁶A甲基化增强非小细胞肺癌中PD-L1的表达并促进免疫逃逸。
Cancer Immunol Immunother. 2025 Mar 3;74(4):132. doi: 10.1007/s00262-025-03986-5.
5
Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.缺氧诱导因子-1α 和核因子-κB 在调节非小细胞肺癌细胞中表皮生长因子受体突变体程序性细胞死亡配体 1 的表达中发挥重要作用。
Cancer Sci. 2019 May;110(5):1665-1675. doi: 10.1111/cas.13989. Epub 2019 Mar 23.
6
Suppression of PD-L1 release from small extracellular vesicles promotes systemic anti-tumor immunity by targeting ORAI1 calcium channels.从小细胞外囊泡中抑制 PD-L1 的释放通过靶向 ORAI1 钙通道促进全身抗肿瘤免疫。
J Extracell Vesicles. 2022 Dec;11(12):e12279. doi: 10.1002/jev2.12279.
7
An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.PD-L1诱导的BAG-1增加通过持续激活ERK信号通路赋予非小细胞肺癌对酪氨酸激酶抑制剂的抗性。
Eur J Cancer. 2017 Nov;85:95-105. doi: 10.1016/j.ejca.2017.07.025. Epub 2017 Sep 9.
8
Targeting the LMP1-ALIX axis in EBV nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity.靶向EBV鼻咽癌中的LMP1-ALIX轴可抑制免疫抑制性小细胞外囊泡的分泌并增强抗肿瘤免疫力。
Cancer Commun (Lond). 2024 Dec;44(12):1391-1413. doi: 10.1002/cac2.12619. Epub 2024 Oct 14.
9
Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.工程化小细胞外囊泡作为 FGL1/PD-L1 双重靶向递药系统,用于缓解免疫排斥。
Adv Sci (Weinh). 2022 Jan;9(3):e2102634. doi: 10.1002/advs.202102634. Epub 2021 Nov 5.
10
IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.IFN-γ 介导的肺癌抑制与 PD-L1 表达相关,并受 PI3K-AKT 信号通路调控。
Int J Cancer. 2018 Aug 15;143(4):931-943. doi: 10.1002/ijc.31357. Epub 2018 Mar 25.

本文引用的文献

1
Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion.鉴定介导多泡体与质膜融合的 SNARE 复合物在 exosome 分泌中的作用。
J Extracell Vesicles. 2023 Sep;12(9):e12356. doi: 10.1002/jev2.12356.
2
The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy.细胞内钙信号传导与外泌体程序性死亡配体1(PD-L1)在癌症进展和免疫治疗中的联系。
Genes Dis. 2023 Mar 24;11(1):321-334. doi: 10.1016/j.gendis.2023.01.026. eCollection 2024 Jan.
3
The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases.
外泌体和多囊泡体(MVBs)的生物发生与分泌:细胞间穿梭及其在人类疾病中的意义
Genes Dis. 2022 Apr 22;10(5):1894-1907. doi: 10.1016/j.gendis.2022.03.021. eCollection 2023 Sep.
4
Identification of a Novel Small Molecule That Enhances the Release of Extracellular Vesicles with Immunostimulatory Potency via Induction of Calcium Influx.鉴定一种新型小分子,通过诱导钙内流增强具有免疫刺激性的细胞外囊泡的释放。
ACS Chem Biol. 2023 Apr 21;18(4):982-993. doi: 10.1021/acschembio.3c00134. Epub 2023 Apr 11.
5
PROTEIN KINASE C ALPHA IS A CENTRAL NODE FOR TUMORIGENIC TRANSCRIPTIONAL NETWORKS IN HUMAN PROSTATE CANCER.蛋白激酶 Cα 是人类前列腺癌致癌转录网络的核心节点。
Cancer Res Commun. 2022 Nov;2(11):1372-1387. doi: 10.1158/2767-9764.crc-22-0170. Epub 2022 Nov 8.
6
Suppression of PD-L1 release from small extracellular vesicles promotes systemic anti-tumor immunity by targeting ORAI1 calcium channels.从小细胞外囊泡中抑制 PD-L1 的释放通过靶向 ORAI1 钙通道促进全身抗肿瘤免疫。
J Extracell Vesicles. 2022 Dec;11(12):e12279. doi: 10.1002/jev2.12279.
7
Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells.解析 PKCα 在腔 A 型乳腺癌细胞中的作用及信号通路。
Int J Mol Sci. 2022 Nov 14;23(22):14023. doi: 10.3390/ijms232214023.
8
Calcium signaling: A therapeutic target to overcome resistance to therapies in cancer.钙信号转导:克服癌症治疗耐药性的治疗靶点。
Cell Calcium. 2022 Dec;108:102673. doi: 10.1016/j.ceca.2022.102673. Epub 2022 Nov 12.
9
PKC-Mediated Orai1 Channel Phosphorylation Modulates Ca Signaling in HeLa Cells.蛋白激酶 C 介导的 Orai1 通道磷酸化调节 HeLa 细胞中的钙信号转导。
Cells. 2022 Jun 27;11(13):2037. doi: 10.3390/cells11132037.
10
Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns.癌症中的小细胞外囊泡程序性死亡配体1:已知与未知
NPJ Precis Oncol. 2022 Jun 21;6(1):42. doi: 10.1038/s41698-022-00287-3.